Galectin Therapeutics
GALT
#9131
Rank
ยฃ62.63 M
Marketcap
ยฃ0.99
Share price
-7.04%
Change (1 day)
-64.57%
Change (1 year)

Earnings for Galectin Therapeutics (GALT)

Earnings in 2024 (TTM): -ยฃ36.8 Million

According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -ยฃ30.84 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Galectin Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 -ยฃ35.34 Million14.56%
2023 -ยฃ30.84 Million5.91%
2022 -ยฃ29.13 Million27.02%
2021 -ยฃ22.93 Million30.1%
2020 -ยฃ17.63 Million76.51%
2019 -ยฃ9.99 Million-4.36%
2018 -ยฃ10.44 Million-14.38%
2017 -ยฃ12.2 Million-24.26%
2016 -ยฃ16.1 Million7.04%
2015 -ยฃ15.04 Million26.85%
2014 -ยฃ11.86 Million30.61%
2013 -ยฃ9.08 Million27.82%
2012 -ยฃ7.11 Million-9.15%
2011 -ยฃ7.82 Million113.17%
2010 -ยฃ3.67 Million-19.86%
2009 -ยฃ4.58 Million14.4%
2008 -ยฃ4 Million-17.49%
2007 -ยฃ4.85 Million-8.41%
2006 -ยฃ5.3 Million5.91%
2005 -ยฃ5 Million-8.89%
2004 -ยฃ5.49 Million47.92%
2003 -ยฃ3.71 Million50.22%
2002 -ยฃ2.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.58 Billion 1,525.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.91 M-164.87%๐Ÿ‡บ๐Ÿ‡ธ USA